The postoperative Model for End stage Liver Disease score as a predictor of short-term outcome after transplantation of extended criteria donor livers

被引:10
|
作者
Benko, Tamas [1 ]
Gallinat, Anja [1 ]
Minor, Thomas [1 ]
Saner, Fuat H. [1 ]
Sotiropoulos, Georgios C. [1 ]
Paul, Andreas [1 ]
Hoyer, Dieter P. [1 ]
机构
[1] Univ Essen Duisburg, Univ Hosp Essen, Dept Gen Visceral & Transplantat Surg, Essen, Germany
关键词
extended criteria donor; liver graft dysfunction; postoperative Model for End stage Liver Disease; risk assessment; EARLY ALLOGRAFT DYSFUNCTION; SINGLE-CENTER EXPERIENCE; PRIMARY NONFUNCTION; GRAFT FUNCTION; MELD; RETRANSPLANTATION; PRESERVATION; DEFINITION; ALLOCATION; RECIPIENTS;
D O I
10.1097/MEG.0000000000000851
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Recently, the postoperative Model for End stage Liver Disease score (POPMELD) was suggested as a definition of postoperative graft dysfunction and a predictor of outcome after liver transplantation (LT). Aim The aim of the present study was to validate this concept in the context of extended criteria donor (ECD) organs. Patients and methods Single-center prospectively collected data (OPAL study/01/11-12/13) of 116 ECD LTs were utilized. For each recipient, the Model for End stage Liver Disease (MELD) score was calculated for 7 postoperative days (PODs). The ability of international normalized ratio, bilirubin, aspartate aminotransferase, Donor Risk Index, a recent definition of early allograft dysfunction, and the POPMELD was compared to predict 90-day graft loss. Predictive abilities were compared by receiver operating characteristic curves, sensitivity and specificity, and positive and negative predictive values. Results The median Donor Risk Index was 1.8. In all, 60.3% of recipients were men [ median age of 54 (23-68) years]. The median POD1-7 peak-aspartate aminotransferase value was 1052 (194-17 577) U/l. The rate of early allograft dysfunction was 22.4%. The 90-day graft survival was 89.7%. Out of possible predictors of the 90-day graft loss MELD on POD5 was the best predictor of outcome (area under the curve = 0.84). A MELD score of 16 or more on POD5 predicted the 90-day graft loss with a specificity of 80.8%, a sensitivity of 81.8%, and a positive and negative predictive value of 31 and 97.7%. Conclusion A MELD score of 16 or more on POD5 is an excellent predictor of outcome in ECD donor LT. Routine evaluation of POPMELD scores might support clinical decision-making and should be reported routinely in clinical trials. Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.
引用
收藏
页码:716 / 722
页数:7
相关论文
共 50 条
  • [31] Donor-Model for End-Stage Liver Disease and Donor-Recipient Matching in Liver Transplantation
    Vitale, A.
    Morales, R. Ramirez
    dalla Bona, E.
    Scopelliti, M.
    Zanus, G.
    Neri, D.
    d'Amico, F.
    Gringeri, E.
    Russo, F.
    Burra, P.
    Angeli, P.
    Cillo, U.
    TRANSPLANTATION PROCEEDINGS, 2011, 43 (04) : 974 - 976
  • [33] A novel scoring system to predict short-term mortality after living donor liver transplantation for acute liver failure
    Shimata, Keita
    Yoon, Young-In
    Hibi, Taizo
    Morinaga, Jun
    Narayanan, Anila Kutty
    Toshima, Takeo
    Ito, Takashi
    Akamatsu, Nobuhisa
    Kotera, Yoshihito
    Hong, Suk Kyun
    Hasegawa, Yasushi
    Umeda, Yuzo
    Reddy, Mettu Srinivas
    Ong, Aldwin De Leon
    Sivaprasadan, Saraswathy
    Varghese, Joy
    Sugawara, Yasuhiko
    Chen, Chao-Long
    Nakayama, Nobuaki
    Mochida, Satoshi
    Tanaka, Atsushi
    Suh, Kyung-Suk
    Ikegami, Toru
    Lee, Kwang-Woong
    Lee, Sung-Gyu
    AMERICAN JOURNAL OF TRANSPLANTATION, 2024, 24 (10) : 1857 - 1867
  • [34] Short-term and long-term outcomes of liver transplantation using moderately and severely steatotic donor livers A systematic review
    Wu, Chenjiao
    Lu, Chao
    Xu, Chengfu
    MEDICINE, 2018, 97 (35)
  • [35] Successful Use of Extended Criteria Donor Grafts With Low to Moderate Steatosis in Patients With Model for End-Stage Liver Disease Scores Below 27
    Avolio, A. W.
    Frongillo, F.
    Nicolotti, N.
    Mule, A.
    Vennarecci, G.
    De Simone, P.
    Agnes, S.
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (01) : 208 - 212
  • [36] Single-Center Experience on Liver Transplantation for Model for End-Stage Liver Disease Score 40 Patients
    Sotiropoulos, Georgios C.
    Vernadakis, Spyridon
    Paul, Andreas
    Hoyer, Dieter P.
    Saner, Fuat H.
    Gallinat, Anja
    DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (11) : 3346 - 3353
  • [37] Development of a Novel Prognostic Nomogram for High Model for End-Stage Liver Disease Score Recipients Following Deceased Donor Liver Transplantation
    Yang, Mengfan
    Khan, Abdul Rehman
    Lu, Di
    Wei, Xuyong
    Shu, Wenzhi
    Xu, Chuanshen
    Pan, Binhua
    Zhou, Zhisheng
    Wang, Rui
    Wei, Qiang
    Cen, Beini
    Cai, Jinzhen
    Zheng, Shusen
    Xu, Xiao
    FRONTIERS IN MEDICINE, 2022, 9
  • [38] Prognostic Value of Model for End-Stage Liver Disease Incorporating with Serum Sodium Score for Development of Acute Kidney Injury after Liver Transplantation
    Cheng, Yuan
    Wei, Guo-Qing
    Cai, Qiu-Cheng
    Jiang, Yi
    Wu, Ai-Ping
    CHINESE MEDICAL JOURNAL, 2018, 131 (11) : 1314 - 1320
  • [39] Model for End-Stage Liver Disease-Sodium Score The Evolution in the Prioritization of Liver Transplantation
    Machicao, Victor Ilich
    CLINICS IN LIVER DISEASE, 2017, 21 (02) : 275 - +
  • [40] Impact of Model for End-stage Liver Disease Score in Post-Liver Transplantation Prognosis
    Annunziata, T. B.
    Paulino, K.
    Fernandes, R.
    Bento, G.
    Stoduto, G.
    Vasconcelos, R.
    Demetrio, L.
    Moreira, L. F. P.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (07) : 2348 - 2351